Bio-Gene Technology Limited
Bio-Gene Technology Limited
Your view on BGT.AX
Overview
What the company does, where it operates, and who runs it.
About Bio-Gene Technology Limited
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Timothy Owen Grogan
- Headquarters
- 456 Lonsdale Street, Melbourne, VIC, AU
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Timothy Owen Grogan
- Headquarters
- 456 Lonsdale Street, Melbourne, VIC, AU
Bio-Gene Technology Limited, an agricultural technology firm based in Australia, focuses on the development and commercialization of insecticides and pesticides. These solutions are designed for a range of uses, encompassing animal health, crop protection, public health, and consumer applications.
The company's key products include Flavocide, an insecticide utilizing beta-triketone technology, and Qcide, a natural oil derived from a specific cultivar of eucalyptus cloeziana.
Bio-Gene maintains a research partnership with James Cook University to develop a tissue culture system, a critical step for expanding tree plantations and increasing future Qcide oil production.
Furthermore, the company collaborates with BASF, the Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries to assess its products' effectiveness against grain storage pests. Established in 1995, Bio-Gene Technology Limited operates from its headquarters in Melbourne, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Bio-Gene Technology Limited. Starting points for Bio-Gene Technology Limited: EPS -AUD 0.0074, beta 0.76 — an Agricultural Inputs name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Bio-Gene Technology Limited. Bio-Gene Technology Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Bio-Gene Technology Limited. Trailing twelve-month EPS for Bio-Gene Technology Limited stands at -AUD 0.0074. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Bio-Gene Technology Limited. Bio-Gene Technology Limited has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ACR.AXAcrux Limited | Healthcare | Biotechnology | — | ||
| BIT.AXBiotron Limited | Healthcare | Biotechnology | — | ||
| CAN.AXCann Group Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| CHM.AXChimeric Therapeutics Limited | Healthcare | Biotechnology | — | ||
| ICR.AXIntelicare Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IXC.AXInvex Therapeutics Ltd | Healthcare | Biotechnology | — | ||
| MEM.AXMemphasys Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| VRDRVerde Resources, Inc. | Basic Materials | OTC | $55.8M | ||
| VVIVFReplenish Nutrients Holding Corp. | Basic Materials | OTC | $14.7M | ||
| YARIYYara International ASA | Basic Materials | OTC | $25.1B | ||
| YRAIFYara International ASA | Basic Materials | OTC | $12.3B | ||
| AGCCFGensource Potash Corporation | Basic Materials | OTC | $31.6M | ||
| ARGO.CNArgo Graphene Solutions Corp. | Basic Materials | CNQ | — | ||
| ARLSFArgo Graphene Solutions Corp. | Basic Materials | OTC | $11.1M | ||
| AVDAmerican Vanguard Corporation | Basic Materials | NYSE | $22.4M | ||
| BEVVFBee Vectoring Technologies International Inc. | Basic Materials | OTC | $1.4M | ||
| BHILQBenson Hill, Inc. | Basic Materials | OTC | — | ||
| BIONQBioNitrogen Holdings Corp. | Basic Materials | OTC | $4,367 | ||
| BIOXBioceres Crop Solutions Corp. | Basic Materials | NASDAQ | $12.8M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Bio-Gene Technology Limited. Coverage tracks Bio-Gene Technology Limited within Agricultural Inputs (Basic Materials). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Bio-Gene Technology Limited.